Mubritinib (TAK 165): A Precision Tool for HER2 and OXPHO...

2026-01-19

Discover how Mubritinib (TAK 165), a potent HER2 inhibitor, is expanding targeted cancer therapy research and revealing new insights into mitochondrial metabolism in cancer biology. This in-depth review provides advanced applications and mechanistic details for HER2-driven cancer and OXPHOS dependency studies.